Login to Your Account



USTR faces litany of trade issues in China and India

By Mari Serebrov
Regulatory Editor

Wednesday, May 7, 2014

Preferring engagement to extreme censure, the U.S. Trade Representative (USTR) hopes to work with officials in China and India this year to create a more even playing field for U.S. medical products in those markets.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription